BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.81% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3401
The Elmet Group
ELMT
$670M
| $13.4M | ﹤0.01% |
+678,055
| New | +$11.6M |
2026 Q2
0 quarters
|
|
3402
Niagen Bioscience
NAGE
$181M
| $13.3M | ﹤0.01% |
4,184,659
+313,040
| +8% | +$1.27M |
2016 Q2
40 quarters
|
|
3403
iQIYI
IQ
$879M
| $13.3M | ﹤0.01% |
12,810,248
+1,159,322
| +10% | +$1.35M |
2018 Q1
33 quarters
|
|
3404
US Gold Corp
USAU
$198M
| $13.3M | ﹤0.01% |
867,174
+159,657
| +23% | +$2.53M |
2021 Q2
20 quarters
|
|
3405
Neumora Therapeutics
NMRA
$91.3M
| $13.2M | ﹤0.01% |
7,791,869
+5,737,553
| +279% | +$10.9M |
2023 Q3
11 quarters
|
|
3406
Daqo New Energy
DQ
$828M
| $13.2M | ﹤0.01% |
988,969
-272,385
| -22% | -$4.94M |
2018 Q2
32 quarters
|
|
3407
Hawthorn Bancshares
HWBK
$288M
| $13.2M | ﹤0.01% |
335,276
+24,604
| +8% | +$881K |
2017 Q1
37 quarters
|
|
3408
Kingsway Corp
KWY
$243M
| $13.2M | ﹤0.01% |
1,262,514
+121,926
| +11% | +$1.32M |
2019 Q2
28 quarters
|
|
3409
HighPeak Energy
HPK
$855M
| $13.2M | ﹤0.01% |
1,881,769
+60,819
| +3% | +$420K |
2021 Q2
20 quarters
|
|
3410
iShares Long-Term National Muni Bond ETF
LMUB
$1.59B
| $13.1M | ﹤0.01% |
256,048
| – | – |
2025 Q1
5 quarters
|
|
3411
Asure Software
ASUR
$313M
| $13.1M | ﹤0.01% |
1,651,498
+139,634
| +9% | +$1.22M |
2017 Q1
37 quarters
|
|
3412
Compass Pathways
CMPS
$1.3B
| $13.1M | ﹤0.01% |
925,391
+242,150
| +35% | +$2.46M |
2021 Q4
18 quarters
|
|
3413
Lantronix
LTRX
$255M
| $13.1M | ﹤0.01% |
2,220,337
+1,920,103
| +640% | +$12.3M |
2017 Q1
37 quarters
|
|
3414
Ring Energy
REI
$297M
| $13.1M | ﹤0.01% |
12,086,312
+10,400,044
| +617% | +$14.5M |
2014 Q1
49 quarters
|
|
3415
LENZ Therapeutics
LENZ
$135M
| $13M | ﹤0.01% |
2,292,121
+315,298
| +16% | +$2.54M |
2021 Q2
20 quarters
|
|
3416
E.W. Scripps
SSP
$331M
| $13M | ﹤0.01% |
4,695,070
-31,489
| -0.7% | -$119K |
2013 Q2
52 quarters
|
|
3417
Shoulder Innovations Inc
SI
$449M
| $12.9M | ﹤0.01% |
638,420
+82,368
| +15% | +$1.26M |
2025 Q3
3 quarters
|
|
3418
Community BanCorp
CMTV
$265M
| $12.9M | ﹤0.01% |
330,212
+259,754
| +369% | +$10M |
2026 Q1
1 quarter
|
|
3419
GH Research
GHRS
$1.32B
| $12.9M | ﹤0.01% |
480,287
+24,669
| +5% | +$515K |
2021 Q4
18 quarters
|
|
3420
Schwab US Broad Market ETF
SCHB
$44.2B
| $12.9M | ﹤0.01% |
445,679
+128,459
| +40% | +$3.6M |
2015 Q4
42 quarters
|
|
3421
EagleRock Land
EROK
$560M
| $12.9M | ﹤0.01% |
+605,848
| New | +$13.1M |
2026 Q2
0 quarters
|
|
3422
First Capital
FCAP
$210M
| $12.8M | ﹤0.01% |
198,569
+24,561
| +14% | +$1.42M |
2017 Q1
37 quarters
|
|
3423
Foghorn Therapeutics
FHTX
$122M
| $12.8M | ﹤0.01% |
2,626,832
+261,966
| +11% | +$1.16M |
2020 Q4
22 quarters
|
|
3424
Opus Genetics
IRD
$349M
| $12.8M | ﹤0.01% |
3,116,487
+2,968,747
| +2,009% | +$13.8M |
2017 Q1
37 quarters
|
|
3425
Information Services Group
III
$287M
| $12.8M | ﹤0.01% |
3,103,567
+330,985
| +12% | +$1.38M |
2016 Q2
40 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.